{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:50:43Z","timestamp":1782485443124,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polycystic ovary syndrome (PCOS) affects up to one in five women of childbearing age. Observational studies assessing the association between maternal PCOS and adverse obstetric outcomes have reported varying results, depending on patient population, diagnostic criteria for PCOS and covariates accounted for in their analyses. We aimed to assess the risk of obstetric outcomes among a population-based representative cohort of women with PCOS compared to an age-matched cohort of women without PCOS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective cohort study was conducted of pregnancies of women in England aged 15\u201349\u00a0years identified from the Clinical Practice Research Datalink (CPRD) GOLD pregnancy register and linked Hospital Episodes Statistic (HES) data between March 1997 and March 2020. Pregnancies from the register that had a linked HES delivery record were included. Linked CPRD primary care data was used to ascertain maternal PCOS exposure prior to pregnancy. To improve detection of PCOS, in addition to PCOS diagnostic codes, codes for (1) polycystic ovaries or (2) hyperandrogenism and anovulation together were also considered. Sensitivity analysis was limited to only pregnant women with a diagnostic code for PCOS.<\/jats:p>\n                <jats:p>Primary outcomes ascertained from linked HES data were (1) preterm delivery (gestation\u2009&lt;\u200937\u00a0weeks), (2) mode of delivery, (3) high (&gt;\u20094000\u00a0g) or low birthweight (&lt;\u20092500\u00a0g) and (4) stillbirth. Secondary outcomes were (1) very preterm delivery (&lt;\u200932\u00a0weeks), (2) extremely preterm delivery (&lt;\u200928\u00a0weeks), (3) small and (4) large for gestational age.<\/jats:p>\n                <jats:p>Conditional logistic regression models were performed adjusting for age, ethnicity, deprivation, dysglycaemia, hypertension, thyroid disorders, number of babies born at index pregnancy, and pre-gravid BMI. Multiple imputation was performed for missing outcome data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>27,586 deliveries with maternal PCOS were matched for age (\u00b1\u20091\u00a0year) to 110,344 deliveries without PCOS. In the fully adjusted models, maternal PCOS was associated with an increased risk of (1) preterm birth [aOR: 1.11 (95% CI 1.06\u20131.17)], and (2) emergency caesarean, elective caesarean and instrumental vaginal compared to spontaneous delivery [aOR: 1.10 (1.05\u20131.15), 1.07 (1.03\u20131.12) and 1.04 (1.00\u20131.09), respectively]. There was absence of association with low birthweight, high birthweight and stillbirth. In the sensitivity analysis, the association with preterm birth [aOR: 1.31 (95% CI 1.13\u20131.52)], emergency caesarean [aOR: 1.15 (95% CI 1.02\u20131.30)], and elective caesarean [aOR: 1.03 (95% CI 1.02\u20131.03)] remained.<\/jats:p>\n                <jats:p>While there was no significant association with any of the secondary outcomes in the primary analysis, in the sensitivity analysis maternal PCOS was associated with increased risk of extremely preterm delivery [aOR: 1.86 (95% CI 1.31\u20132.65)], and lower risk of small for gestational age babies [aOR: 0.74 (95% CI 0.59\u20130.94)].<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Maternal PCOS was associated with increased risk of preterm and caesarean delivery. Association with low birthweight may be largely mediated by lower gestational age at birth.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-022-02473-3","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:02:16Z","timestamp":1661817736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England"],"prefix":"10.1186","volume":"20","author":[{"given":"Anuradhaa","family":"Subramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siang Ing","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos A.","family":"Toulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punith","family":"Kempegowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola J.","family":"Adderley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakila","family":"Thangaratinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Arlt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnarajah","family":"Nirantharakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"2473_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3399\/bjgp18X696101","volume":"68","author":"SC Hillman","year":"2018","unstructured":"Hillman SC, Dale J. Polycystic ovarian syndrome: an under-recognised problem? Br J Gen Pract. 2018;68:244\u2013244.","journal-title":"Br J Gen Pract"},{"key":"2473_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012461","volume":"6","author":"T Ding","year":"2016","unstructured":"Ding T, Baio G, Hardiman PJ, Petersen I, Sammon C. Diagnosis and management of polycystic ovary syndrome in the UK (2004\u20132014): a retrospective cohort study. BMJ Open. 2016;6: e012461.","journal-title":"BMJ Open"},{"key":"2473_CR3","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-Analysis. Hum Reprod. 2016;31:2841\u201355.","journal-title":"Hum Reprod"},{"key":"2473_CR4","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1093\/humrep\/deab101","volume":"36","author":"RC Fernandez","year":"2021","unstructured":"Fernandez RC, et al. Diagnosis delayed: health profile differences between women with undiagnosed polycystic ovary syndrome and those with a clinical diagnosis by age 35 years. Hum Reprod. 2021;36:2275\u201384.","journal-title":"Hum Reprod"},{"key":"2473_CR5","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33:1602\u201318.","journal-title":"Hum Reprod"},{"key":"2473_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","volume":"502","author":"X Zeng","year":"2020","unstructured":"Zeng X, Xie Jie Y, Ting Liu Y, Lian Long S, Cheng Mo Z. Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020;502:214\u201321.","journal-title":"Clin. Chim. Acta."},{"key":"2473_CR7","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1530\/EJE-16-0373","volume":"176","author":"D Glintborg","year":"2017","unstructured":"Glintborg D, Andersen M. MANAGEMENT OF ENDOCRINE DISEASE: Morbidity in polycystic ovary syndrome. Eur J Endocrinol. 2017;176:R53\u201365.","journal-title":"Eur J Endocrinol"},{"key":"2473_CR8","first-page":"e4863","volume":"95","author":"HF Yu","year":"2016","unstructured":"Yu HF, Chen HS, Rao DP, Gong J. Association between polycystic ovary syndrome and the risk of pregnancy complications A PRISMA-compliant systematic review and meta-analysis. Med.\u00a0 (United States). 2016;95:e4863.","journal-title":"Med.\u00a0 (United States)."},{"issue":"2","key":"2473_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41574-019-0314-3","volume":"16","author":"A Morris","year":"2019","unstructured":"Morris A. Transgenerational effects of polycystic ovary syndrome identified. Nat Rev Endocrinol. 2019;16(2):67.","journal-title":"Nat Rev Endocrinol."},{"key":"2473_CR10","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2147\/IJWH.S70314","volume":"7","author":"S Palomba","year":"2015","unstructured":"Palomba S, Santagni S, Falbo A, La Sala GB. Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health. 2015;7:745.","journal-title":"Int J Womens Health"},{"issue":"558","key":"2473_CR11","first-page":"e1","volume":"204","author":"LE Kjerulff","year":"2011","unstructured":"Kjerulff LE, Sanchez-Ramos L, Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. Am J Obstet Gynecol. 2011;204(558):e1-558.e6.","journal-title":"Am J Obstet Gynecol"},{"key":"2473_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7827-11-56","volume":"11","author":"JZ Qin","year":"2013","unstructured":"Qin JZ, et al. Obstetric complications in women with polycystic ovary syndrome: A systematic review and meta-analysis. Reprod Biol Endocrinol. 2013;11:1\u201314.","journal-title":"Reprod Biol Endocrinol"},{"key":"2473_CR13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/humupd\/dml036","volume":"12","author":"CM Boomsma","year":"2006","unstructured":"Boomsma CM, et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12:673\u201383.","journal-title":"Hum Reprod Update"},{"key":"2473_CR14","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/humrep\/dem028","volume":"22","author":"S Hu","year":"2007","unstructured":"Hu S, Leonard A, Seifalian A, Hardiman P. Vascular dysfunction during pregnancy in women with polycystic ovary syndrome. Hum Reprod. 2007;22:1532\u20139.","journal-title":"Hum Reprod"},{"key":"2473_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.fertnstert.2008.04.022","volume":"92","author":"M Maliqueo","year":"2009","unstructured":"Maliqueo M, et al. Metabolic parameters in cord blood of newborns of women with polycystic ovary syndrome. Fertil Steril. 2009;92:277\u201382.","journal-title":"Fertil Steril"},{"key":"2473_CR16","doi-asserted-by":"publisher","first-page":"d6309","DOI":"10.1136\/bmj.d6309","volume":"343","author":"N Roos","year":"2011","unstructured":"Roos N, et al. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: Population based cohort study. BMJ. 2011;343:d6309.","journal-title":"BMJ."},{"key":"2473_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5653\/cerm.2011.38.2.103","volume":"38","author":"AR Han","year":"2011","unstructured":"Han AR, et al. Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control study. Clin Exp Reprod Med. 2011;38:103\u20138.","journal-title":"Clin Exp Reprod Med"},{"key":"2473_CR18","doi-asserted-by":"publisher","first-page":"117955811987404","DOI":"10.1177\/1179558119874042","volume":"13","author":"TM Barber","year":"2019","unstructured":"Barber TM, Hanson P, Weickert MO, Franks S. Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies. Clin Med Insights Reprod Heal. 2019;13:117955811987404.","journal-title":"Clin Med Insights Reprod Heal"},{"issue":"189","key":"2473_CR19","first-page":"e1","volume":"217","author":"JL Chan","year":"2017","unstructured":"Chan JL, et al. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study. Am J Obstet Gynecol. 2017;217(189):e1-189.e8.","journal-title":"Am J Obstet Gynecol"},{"key":"2473_CR20","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.2337\/dc21-0437","volume":"44","author":"B Kumarendran","year":"2021","unstructured":"Kumarendran B, et al. Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study. Diabetes Care. 2021;44:2758\u201366.","journal-title":"Diabetes Care"},{"key":"2473_CR21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3389\/fmed.2020.574651","volume":"7","author":"CH Wu","year":"2020","unstructured":"Wu CH, et al. Hypertension Risk in Young Women With Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study. Front Med. 2020;7:585.","journal-title":"Front Med"},{"key":"2473_CR22","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1530\/EJE-14-0295","volume":"172","author":"S Gaber\u0161\u010dek","year":"2015","unstructured":"Gaber\u0161\u010dek S, et al. MECHANISMS IN ENDOCRINOLOGY: Thyroid and polycystic ovary syndrome. Eur J Endocrinol. 2015;172:R9\u201321.","journal-title":"Eur J Endocrinol"},{"key":"2473_CR23","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, et al. Data Resource Profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44:827\u201336.","journal-title":"Int J Epidemiol"},{"key":"2473_CR24","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/pds.4811","volume":"28","author":"C Minassian","year":"2019","unstructured":"Minassian C, et al. Methods to generate and validate a Pregnancy Register in the UK Clinical Practice Research Datalink primary care database. Pharmacoepidemiol Drug Saf. 2019;28:923\u201333.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"2473_CR25","doi-asserted-by":"publisher","first-page":"e1002542","DOI":"10.1371\/journal.pmed.1002542","volume":"15","author":"B Kumarendran","year":"2018","unstructured":"Kumarendran B, et al. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database. PLoS Med. 2018;15(3):e1002542.","journal-title":"PLoS Med."},{"key":"2473_CR26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0140-6736(14)60932-6","volume":"384","author":"J Villar","year":"2014","unstructured":"Villar J, et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet. 2014;384:857\u201368.","journal-title":"Lancet"},{"key":"2473_CR27","unstructured":"The English Indices of Deprivation 2019 (IoD2019).\u00a02019. https:\/\/www.gov.uk\/government\/publications\/english-indices-of-deprivation-2019-technical-report. Accessed 27 Feb\u00a02022."},{"key":"2473_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-017-0414-5","volume":"17","author":"TR Sullivan","year":"2017","unstructured":"Sullivan TR, Lee KJ, Ryan P, Salter AB. Multiple imputation for handling missing outcome data when estimating the relative risk. BMC Med Res Methodol. 2017;17:1\u201310.","journal-title":"BMC Med Res Methodol"},{"key":"2473_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-017-0442-1","volume":"17","author":"JC Jakobsen","year":"2017","unstructured":"Jakobsen JC, Gluud C, Wetterslev J, Winkel P. When and how should multiple imputation be used for handling missing data in randomised clinical trials - A practical guide with flowcharts. BMC Med Res Methodol. 2017;17:1\u201310.","journal-title":"BMC Med Res Methodol"},{"key":"2473_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-016-0281-5","volume":"17","author":"E Kontopantelis","year":"2017","unstructured":"Kontopantelis E, White IR, Sperrin M, Buchan I. Outcome-sensitive multiple imputation: A simulation study. BMC Med Res Methodol. 2017;17:1\u201313.","journal-title":"BMC Med Res Methodol"},{"key":"2473_CR31","doi-asserted-by":"publisher","unstructured":"Thirumala Krishna M,  et al. Allergic diseases and long-term risk of autoimmune disorders: longitudinal cohort study and cluster analysis. doi:https:\/\/doi.org\/10.1183\/13993003.00476-2019.","DOI":"10.1183\/13993003.00476-2019"},{"key":"2473_CR32","unstructured":"Hospital Episode Statistics (HES) - NHS Digital. https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/hospital-episode-statistics."},{"key":"2473_CR33","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/humrep\/deaa099","volume":"35","author":"G Mills","year":"2020","unstructured":"Mills G, Badeghiesh A, Suarthana E, Baghlaf H, Dahan MH. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies. Hum Reprod. 2020;35:1666\u201374.","journal-title":"Hum Reprod."},{"key":"2473_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-019-4128-0","volume":"12","author":"G Mulualem","year":"2019","unstructured":"Mulualem G, Wondim A, Woretaw A. The effect of pregnancy induced hypertension and multiple pregnancies on preterm birth in Ethiopia: A systematic review and meta-analysis. BMC Res Notes. 2019;12:1\u20137.","journal-title":"BMC Res Notes"},{"key":"2473_CR35","first-page":"850","volume":"102","author":"MM Hedderson","year":"2003","unstructured":"Hedderson MM, Ferrara A, Sacks DA. Gestational diabetes mellitus and lesser degrees of pregnancy hyperglycemia: association with increased risk of spontaneous preterm birth. Obstet Gynecol. 2003;102:850\u20136.","journal-title":"Obstet Gynecol"},{"key":"2473_CR36","unstructured":"Recommendations | Preterm labour and birth | Guidance | NICE. https:\/\/www.nice.org.uk\/guidance\/ng25\/chapter\/Recommendations#mode-of-birth."},{"key":"2473_CR37","doi-asserted-by":"publisher","first-page":"e4863","DOI":"10.1097\/MD.0000000000004863","volume":"95","author":"HF Yu","year":"2016","unstructured":"Yu HF, Chen HS, Rao DP, Gong J. Association between polycystic ovary syndrome and the risk of pregnancy complications: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2016;95:e4863.","journal-title":"Medicine (Baltimore)."},{"key":"2473_CR38","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/humupd\/dmv029","volume":"21","author":"S Palomba","year":"2015","unstructured":"Palomba S, et al. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015;21:575\u201392.","journal-title":"Hum Reprod Update"},{"key":"2473_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.23736\/S2724-606X.21.04758-4","volume":"74","author":"MN d\u2019Alterio","year":"2022","unstructured":"d\u2019Alterio MN, et al. Pregnancy outcomes in women with polycystic ovarian syndrome. Minerva Obstet Gynecol. 2022;74:45\u201359.","journal-title":"Minerva Obstet Gynecol"},{"key":"2473_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246743","volume":"16","author":"H Valgeirsdottir","year":"2021","unstructured":"Valgeirsdottir H, et al. Polycystic ovary syndrome and extremely preterm birth: A nationwide register-based study. PLoS ONE. 2021;16: e0246743.","journal-title":"PLoS ONE"},{"key":"2473_CR41","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1056\/NEJMoa1612665","volume":"377","author":"G Zhang","year":"2017","unstructured":"Zhang G, et al. Genetic Associations with Gestational Duration and Spontaneous Preterm Birth. N Engl J Med. 2017;377:1156\u201367.","journal-title":"N Engl J Med"},{"key":"2473_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12958-021-00706-3","volume":"19","author":"P Devarbhavi","year":"2021","unstructured":"Devarbhavi P, et al. Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules. Reprod Biol Endocrinol. 2021;19:31.","journal-title":"Reprod Biol Endocrinol"},{"key":"2473_CR43","doi-asserted-by":"publisher","first-page":"204201882093431","DOI":"10.1177\/2042018820934319","volume":"11","author":"P Kempegowda","year":"2020","unstructured":"Kempegowda P, Melson E, Manolopoulos KN, Arlt W, O\u2019Reilly MW. Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2020;11:204201882093431.","journal-title":"Ther Adv Endocrinol Metab."},{"key":"2473_CR44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/aje\/kwf176","volume":"157","author":"N Dole","year":"2003","unstructured":"Dole N, et al. Maternal stress and preterm birth. Am J Epidemiol. 2003;157:14\u201324.","journal-title":"Am J Epidemiol"},{"key":"2473_CR45","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1111\/1471-0528.16890","volume":"128","author":"H Valgeirsdottir","year":"2021","unstructured":"Valgeirsdottir H, et al. Polycystic ovary syndrome and risk of stillbirth: a nationwide register-based study. BJOG An Int J Obstet Gynaecol. 2021;128:2073\u201382.","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"2473_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hropen\/hoy019","volume":"2018","author":"S Holton","year":"2018","unstructured":"Holton S, Hammarberg K, Johnson L. Fertility concerns and related information needs and preferences of women with PCOS. Hum Reprod Open. 2018;2018:1\u20137.","journal-title":"Hum Reprod Open"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02473-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-022-02473-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02473-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T10:06:34Z","timestamp":1668679594000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-022-02473-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2473"],"URL":"https:\/\/doi.org\/10.1186\/s12916-022-02473-3","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,30]]},"assertion":[{"value":"23 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Observational research using CPRD data was approved by National Research Ethics Service Committee. This study has been approved by the Independent Scientific Advisory Committee (Reference: 21_000412). As CPRD data are anonymized, individual patients are not required to give consent for the use of their data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"298"}}